Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3,Condition 4 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,female,63 days to 49 days,8,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,23.1566,IU/g,1.5524,4.3909,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours),48843,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 1.5 hours), 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,male,63 days to 49 days,10,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,20.1553,IU/g,1.4079,4.4522,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours),48847,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 1.5 hours), 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,female,63 days to 49 days,10,,CMO:0000198,arterial blood flow rate,,,,11.566,ml/min/g,0.6406,2.0257,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),46683,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,male,63 days to 49 days,9,,CMO:0000198,arterial blood flow rate,,,,11.6389,ml/min/g,0.6727,2.0181,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),46688,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,female,63 days to 49 days,10,,CMO:0000198,arterial blood flow rate,,,,5.184,ml/min/g,0.8712,2.7551,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),44748,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,male,63 days to 49 days,8,,CMO:0000198,arterial blood flow rate,,,,4.6325,ml/min/g,0.6802,1.9238,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),44753,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,female,63 days to 49 days,8,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,13.7909,IU/g,1.6968,4.7993,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours),45954,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 1.5 hours) 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,male,63 days to 49 days,8,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,18.7217,IU/g,2.3705,6.7048,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours),45958,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 1.5 hours) 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,female,63 days to 49 days,8,,CMO:0000198,arterial blood flow rate,,,,9.3975,ml/min/g,0.6833,1.9327,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),46900,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,male,63 days to 49 days,10,,CMO:0000198,arterial blood flow rate,,,,9.274,ml/min/g,0.5956,1.8836,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),46905,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,, 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,female,63 days to 49 days,8,,CMO:0000749,percent change in arterial blood flow rate,post-ischemic value/pre-ischemic value x 100%,,,57.4452,%,5.1949,14.6933,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46096,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours), 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,male,63 days to 49 days,10,,CMO:0000749,percent change in arterial blood flow rate,post-ischemic value/pre-ischemic value x 100%,,,47.1706,%,2.8659,9.0629,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46101,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours), 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,female,63 days to 49 days,10,,CMO:0000749,percent change in arterial blood flow rate,post-ischemic value/pre-ischemic value x 100%,,,43.0906,%,4.9445,15.6358,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),47107,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,male,63 days to 49 days,8,,CMO:0000749,percent change in arterial blood flow rate,post-ischemic value/pre-ischemic value x 100%,,,40.2894,%,4.6704,13.21,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),47112,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours) 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,female,63 days to 49 days,8,,CMO:0000198,arterial blood flow rate,,,,5.3375,ml/min/g,0.5564,1.5737,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46231,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours), 461,PhysGen Cardiac data,arterial blood flow trait,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,male,63 days to 49 days,10,,CMO:0000198,arterial blood flow rate,,,,4.416,ml/min/g,0.4408,1.3941,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours),46236,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),perfusate suspended (for 0.4 hours),controlled oxygen content Kreb's solution perfusate (for 0.7 hours), 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,female,63 days to 49 days,8,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,0.3986,IU/g,0.0816,0.2309,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47285,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,, 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,male,63 days to 49 days,10,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,0.3332,IU/g,0.0537,0.1697,MMO:0000114,isolated perfused heart effluent collection,,,,,,,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47292,controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,, 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,female,63 days to 49 days,10,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,0.2819,IU/g,0.0692,0.2187,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47427,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),, 461,PhysGen Cardiac data,heart lactate dehydrogenase activity,Moms and pups used in studies were fed Teklad,RS:0000334,FHH-Chr 5BN/Mcwi,male,63 days to 49 days,9,,CMO:0000775,heart effluent lactate dehydrogenase activity level normalized to heart weight,,,,0.4322,IU/g,0.0746,0.2237,MMO:0000114,isolated perfused heart effluent collection,,,,,,,air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours),47434,air oxygen content (12 %) (for 14 days),controlled oxygen content Kreb's solution perfusate (for 0.5 hours),,